Physiological Basis of Glaucomatous Visual Field Defects

Primary Pathophysiological Mechanism

Glaucoma is fundamentally a chronic, progressive optic neuropathy characterized by acquired atrophy of the optic nerve and loss of retinal ganglion cells (RGCs) and their axons, according to the American Academy of Ophthalmology 1, 2
Axonal degeneration of RGC fibers as they pass through the lamina cribrosa and form the optic nerve is a key aspect of the disease, as noted by the American Academy of Ophthalmology 1

The characteristic visual field defects in glaucoma directly reflect the anatomical organization of retinal nerve fiber bundles, with arcuate nerve fiber bundles from the superior and inferior retina being preferentially damaged, especially at the superior and inferior poles of the optic disc, as described by the American Academy of Ophthalmology 1, 2, 3
This anatomical vulnerability produces the classic arcuate scotomas (arcuate field defects) that respect the horizontal midline, according to the American Academy of Ophthalmology 1, 2, 3
Nasal step defects occur when damage affects the arcuate bundles asymmetrically, as noted by the American Academy of Ophthalmology 1, 3
Paracentral depressions in clusters of test sites represent focal areas of RGC loss, according to the American Academy of Ophthalmology 1, 2

Early stage glaucoma is characterized by diffuse or localized RNFL thinning, particularly at inferior or superior poles, often preceding detectable visual field defects, as described by the American Academy of Ophthalmology 4
Moderate stage glaucoma is marked by visual field abnormalities appearing in one hemifield but remaining outside 5 degrees of fixation, according to the American Academy of Ophthalmology 1, 2
Severe stage glaucoma is characterized by visual field abnormalities affecting both hemifields and/or involving loss within 5 degrees of fixation in at least one hemifield, as noted by the American Academy of Ophthalmology 1, 2

Elevated intraocular pressure (IOP) is the major modifiable risk factor that triggers RGC death and optic nerve damage, though nearly 40% of patients with characteristic glaucomatous damage may not have elevated IOP measurements during office hours, according to the American Academy of Ophthalmology 1, 2
Lowering IOP reduces the risk of developing glaucoma and slows disease progression, as described by the American Academy of Ophthalmology 1, 3
A reasonable initial treatment goal is to reduce IOP 20-30% below baseline, according to the American Academy of Ophthalmology 1, 2

Structural optic nerve damage often precedes detectable visual field defects on standard automated perimetry, emphasizing the critical importance of careful optic nerve head and RNFL examination for early detection, as noted by the American Academy of Ophthalmology 4